Hacking the ribosome to map virus-host associations
The VirHoX project aims to map virus-host associations using a novel technique, VirHo-seq, to enhance understanding of viral interactions and address challenges posed by emerging pathogens.
Projectdetails
Introduction
High throughput sequencing and metagenomics have deepened our understanding of viruses in nature, yet linking viruses to their hosts remains a challenge, hindering our knowledge and applications.
Project Aim
The VirHoX project aims to overcome this by "hacking" the ribosome to map virus-host associations. Leveraging a critical moment in the infection cycle of all viruses, the translation of viral genes into proteins by the host cell, we will uncover concealed relationships between viruses and their hosts, providing a universal tool for virus-host pairing.
Methodology
This novel approach, VirHo-seq, involves:
- Ligating host ribosomal RNA with viral mRNA during translation in infected cells using engineered enzymes.
- Following this with high throughput sequencing to reveal virus-host pairings.
Consortium
Our interdisciplinary consortium consists of academic and industrial experts in:
- Microbiology
- Protein engineering
- Gene editing
- Viral genomics/transcriptomics
- Law
We will develop and then prepare the commercialization of VirHo-seq, envisioning legislative and analytical frameworks to maximize its impact.
Impact
This technology will significantly help tackle current challenges, such as those posed by:
- Emerging pathogens
- Ecological disruptions
- Climate change
Alignment with Objectives
Our approach aligns with the EIC Work Programme objectives, demonstrating feasibility on model organisms before validating on relevant samples, addressing the "engineered living materials" challenge.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 3.000.000 |
Totale projectbegroting | € 3.000.000 |
Tijdlijn
Startdatum | 1-2-2025 |
Einddatum | 31-1-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- UNIVERSITA DEGLI STUDI DI PADOVApenvoerder
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- UNIVERSITA DEGLI STUDI DI TRIESTE
- UNIVERSITETET I OSLO
- INSTITUT PASTEUR
- INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA
- FIZ KARLSRUHE - LEIBNIZ-INSTITUT FUR INFORMATIONSINFRASTRUKTUR GMBH
- Eubiome Srl
Land(en)
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Deciphering the nanobiophysics of virus-host interactions in 3D cellular systemsThis project aims to elucidate virus-host interactions during entry in 3D environments using advanced nanotechniques, potentially leading to new antiviral drug discoveries. | ERC Consolid... | € 2.867.346 | 2023 | Details |
Traitor-virus-guided discovery of antiviral factorsThis project aims to use CRISPR/Cas9 technology with HIV-1 to uncover antiviral mechanisms, enhancing our understanding and control of viral pathogens for better prevention and therapy. | ERC Advanced... | € 2.339.875 | 2022 | Details |
Molecular dissection of viral genomes for future antiviral treatmentsThis project aims to identify and characterize virus-encoded transmembrane proteins as novel pharmaceutical targets for antiviral drug discovery and treatment of viral infections. | ERC Advanced... | € 2.420.301 | 2023 | Details |
Dynamics and heterogeneity of early viral infectionThis project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Archaeal Virology: unravelling the mechanisms of interviral warfareThis project aims to investigate viral mechanisms that enable competition among viruses infecting archaea, with potential applications in enhancing human health and reducing methane emissions. | ERC Starting... | € 1.500.000 | 2022 | Details |
Deciphering the nanobiophysics of virus-host interactions in 3D cellular systems
This project aims to elucidate virus-host interactions during entry in 3D environments using advanced nanotechniques, potentially leading to new antiviral drug discoveries.
Traitor-virus-guided discovery of antiviral factors
This project aims to use CRISPR/Cas9 technology with HIV-1 to uncover antiviral mechanisms, enhancing our understanding and control of viral pathogens for better prevention and therapy.
Molecular dissection of viral genomes for future antiviral treatments
This project aims to identify and characterize virus-encoded transmembrane proteins as novel pharmaceutical targets for antiviral drug discovery and treatment of viral infections.
Dynamics and heterogeneity of early viral infection
This project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies.
Archaeal Virology: unravelling the mechanisms of interviral warfare
This project aims to investigate viral mechanisms that enable competition among viruses infecting archaea, with potential applications in enhancing human health and reducing methane emissions.